[Antilipemic and hyperglycemic heparin effects in alloxan diabetes].
D000818:Animals; D001769:Blood; D003921:Diabetes Mellitus, Experimental; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D000960:Hypolipidemic Agents; D008055:Lipids / Q000097:blood*
D000960:Hypolipidemic Agents; D008055:Lipids; D006493:Heparin
BLOOD; DIABETES MELLITUS/experimental; HEPARIN/effects; LIPIDS/in blood
Antilipämische und hyperglykämische Heparinwirkung bei Alloxandiabetes.